FT Health Examines Benefits, Dangers Of Data During COVID-19 Pandemic, Features Interview With Epidemiologist David Heymann

FT Health: The dangers of data
The Financial Times’ monthly global health and finance newsletter highlights how “technology has proved valuable during the coronavirus pandemic in helping rapidly collect and analyze information for clinicians, drug developers, and policymakers alike. But it has also contributed to an ‘infodemic’ of distorted analysis, fueling misleading information and a politicization of prevention measures, from lockdowns to the wisdom of wearing face masks.” The newsletter also features an interview with epidemiology expert David Heymann and a roundup of global health-related news stories (Jack/Dodd, 11/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.